Although the molecular mechanisms underlying pathological tau accumulation and mislocalization in AD have not been fully elucidated, recent studies have revealed a possible involvement of tau degradation deficiency in the disruption of tau homeostasis.6 The gene discussed is MAPT; the disease is Alzheimer disease.